Who is sponsoring NCT03153020?

NCT03153020 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT03153020?

Interventions in NCT03153020: Patients with stroke or transient ischemic attack.

What condition does NCT03153020 study?

NCT03153020 studies Stroke, Transient Ischemic Attack.

Is NCT03153020 still recruiting?

NCT03153020 is currently completed. Last updated 25 November 2025.

Last reviewed 2025-11-25 · How we verify

NCT03153020: OBSTACLE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône

Completed Last updated 25 November 2025

What this trial tests

trial testing Patients with stroke or transient ischemic attack in Stroke in 633 participants. Completed in 31 December 2019.

Timeline

11 September 2017

Primary endpoint
31 December 2018

31 December 2019

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Completed
Study type	OBSERVATIONAL
Enrollment	633
Start date	11 September 2017
Primary completion	31 December 2018
Estimated completion	31 December 2019
Sites	1 location across France

Drugs / interventions tested

Patients with stroke or transient ischemic attack

Conditions studied

Stroke — all drugs for Stroke →
Transient Ischemic Attack — all drugs for Transient Ischemic Attack →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

18 and older, any sex, with Stroke or Transient Ischemic Attack. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effectiveness of emergency management of acute ischemic stroke has improved considerably in recent years with thrombolysis and more recently thrombectomy. This improvement is accompanied by an increase in the number of stroke survivors. One of the major issues for these ever-increasing survivors is the prevention of recurrence. According to data from the 3 French registries, more than 20% of patients have at least one recurrence. Secondary prevention treatment has demonstrated his efficacy to prevent stroke recurrence. This evolution justifies identifying factors associated with adherence to secondary prevention treatment, measured at 1 year post-stroke / transient ischemic attack (TIA), in patients included in the STROKE 69 cohort.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack.
Viprey M, Gouillet M, Puppo C, Termoz A, et al · · 2020 · cited 3× · PMID 32801652 · DOI 10.2147/ppa.s257323
Determinants of adherence to post-stroke/transient ischemic attack secondary prevention medications: A cohort study.
Hoarau D, Ramos I, Termoz A, Fernandez V, et al · · 2024 · cited 2× · PMID 38953278 · DOI 10.1111/ene.16395
European Stroke Organisation Conference: Abstracts
· 2018

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03153020 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 25 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03153020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing